Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 138Neoplasms 5Neoplasm Metastasis 4Prostate Adenocarcinoma 3Recurrence 2Osteoporosis 2Advanced Prostate Cancer 2Stage I Prostate Adenocarcinoma AJCC v7 1Sexual Dysfunction, Physiological 1Sarcopenia 1Radiation Injuries 1Primary Dysautonomias 1Patients With T1-4 Advanced Prostate Cancer 1PSA Level Greater Than Two 1Lymphatic Metastasis 1Kidney Diseases 1Hypertension 1Hot Flashes 1Hormone Sensitive Prostate Cancer 1Castration-resistant Prostate Cancer Patients with Oligometastases 1Castrate Sensitive Prostate Cancer 1Anemia 1

Interventions

luprolide acetate gel depot 1bicalutamide 1Radiotherapy, Intensity-Modulated 1Leuprolide 1Goserelin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
PSA Level Greater Than Two × Goserelin × Genitourinary × Clear all
NCT00544830 2026-05-15

Hormone Therapy and Intensity-Modulated Radiation Therapy in Treating Patients With Metastatic Prostate Cancer

City of Hope Medical Center

Phase 2 Active not recruiting
29 enrolled 12 charts
Genitourinary

PSA Level Greater Than Two

Data powered by HemOnc (CC BY 4.0) Colophon âš¡